Back to calendar
Supernus Pharmaceuticals, Inc. (SUPN) Earnings
SUPN reports earnings on Tuesday, November 10, 2026
earnings report
November 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.61
Actual EPS: $0.53
EPS surprise: 24.51%
Company overview
Market Cap$2.4B
PriceUSD 40.90
EPS (TTM)-1.91
52-week high59.68
52-week low40.82
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees778